Bacterial carbonic anhydrase as a candidate vaccine target against .
作者信息
Buzás György M
机构信息
Ferencváros Health Centre, Department of Gastroenterology, Budapest, Hungary.
出版信息
Front Microbiol. 2025 Apr 9;16:1541387. doi: 10.3389/fmicb.2025.1541387. eCollection 2025.
Abstract
摘要
相似文献
1
Bacterial carbonic anhydrase as a candidate vaccine target against .
Front Microbiol. 2025 Apr 9;16:1541387. doi: 10.3389/fmicb.2025.1541387. eCollection 2025.
2
Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Bioorg Med Chem Lett. 2007 Jul 1;17(13):3585-94. doi: 10.1016/j.bmcl.2007.04.063. Epub 2007 Apr 25.
3
Erlotinib-containing benzenesulfonamides as anti- agents through carbonic anhydrase inhibition.
Future Med Chem. 2023 Oct;15(20):1865-1883. doi: 10.4155/fmc-2023-0208. Epub 2023 Oct 27.
4
Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
J Med Chem. 2006 Mar 23;49(6):2117-26. doi: 10.1021/jm0512600.
5
Novel carbonic anhydrase inhibitors for the treatment of infection.
Expert Opin Investig Drugs. 2024 May;33(5):523-532. doi: 10.1080/13543784.2024.2334714. Epub 2024 Mar 27.
6
Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2182-8. doi: 10.1016/j.bmcl.2006.01.044. Epub 2006 Feb 3.
7
The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
Curr Pharm Des. 2008;14(7):622-30. doi: 10.2174/138161208783877875.
8
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of .
J Enzyme Inhib Med Chem. 2022 Dec;37(1):51-61. doi: 10.1080/14756366.2021.1991336.
9
Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?
J Cell Mol Med. 2005 Jul-Sep;9(3):741-4. doi: 10.1111/j.1582-4934.2005.tb00506.x.
10
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.
Helicobacter. 2005 Apr;10(2):136-8. doi: 10.1111/j.1523-5378.2005.00306.x.
本文引用的文献
1
A multivalent mRNA-LNP vaccine protects against infection.
Science. 2024 Oct 4;386(6717):69-75. doi: 10.1126/science.adn4955. Epub 2024 Oct 3.
2
Outer Membrane Vesicles: Biogenesis, Composition, and Biological Functions.
Int J Biol Sci. 2024 Jul 15;20(10):4029-4043. doi: 10.7150/ijbs.94156. eCollection 2024.
3
Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles.
Sci Rep. 2024 Aug 2;14(1):17910. doi: 10.1038/s41598-024-68947-x.
4
Novel carbonic anhydrase inhibitors for the treatment of infection.
Expert Opin Investig Drugs. 2024 May;33(5):523-532. doi: 10.1080/13543784.2024.2334714. Epub 2024 Mar 27.
5
Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a vaccine candidate.
mBio. 2024 Mar 13;15(3):e0295223. doi: 10.1128/mbio.02952-23. Epub 2024 Feb 20.
6
Leveraging immunoinformatics for developing a multi-epitope subunit vaccine against and .
J Biomol Struct Dyn. 2025 Feb;43(3):1552-1565. doi: 10.1080/07391102.2023.2292295. Epub 2023 Dec 20.
7
Expression and purification of epitope vaccine against four virulence proteins from Helicobacter pylori and construction of label-free electrochemical immunosensor.
Biosens Bioelectron. 2023 Dec 15;242:115720. doi: 10.1016/j.bios.2023.115720. Epub 2023 Oct 4.
8
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa.
NPJ Vaccines. 2023 May 25;8(1):76. doi: 10.1038/s41541-023-00672-4.
9
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis.
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):553-564. doi: 10.1016/S2468-1253(23)00070-5. Epub 2023 Apr 20.
10
Baculovirus-mediated expression of a Helicobacter pylori protein-based multiepitope hybrid gene induces a potent B cell response in mice.
Immunobiology. 2023 Mar;228(2):152334. doi: 10.1016/j.imbio.2023.152334. Epub 2023 Jan 9.
Zotero 插件